🇺🇸 FDA
Patent

US 9623097

Yeast-brachyury immunotherapeutic compositions

granted A61KA61K2039/51A61K2039/545

Quick answer

US patent 9623097 (Yeast-brachyury immunotherapeutic compositions) held by The United States of America as Represented by the Secretary, Dept. of Health and Human Services expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary, Dept. of Health and Human Services
Grant date
Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K2039/51, A61K2039/545, A61K2039/55511, A61K2039/6006